(MIST) - FDA

(MIST) – FDA

Apr 8, 2024 11:36 AM Milestone Pharmaceuticals (MIST) Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at ACC
Mar 28, 2024 07:00 AM Milestone Pharmaceuticals Inc. (MIST) Resubmits NDA for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
Feb 26, 2024 07:04 AM
Dec 26, 2023 07:03 AM
Nov 13, 2023 05:32 AM
Oct 24, 2023 07:05 AM
Jun 20, 2023 07:01 AM
Nov 7, 2022 12:13 PM
Oct 17, 2022 06:00 AM
May 17, 2021 07:03 AM
Mar 30, 2021 06:09 AM
Jul 23, 2020 08:06 AM
Jul 23, 2020 07:15 AM
Mar 23, 2020 04:11 PM
Oct 3, 2019 07:03 AM